Midterm Outcomes of Zone 0 Antegrade Endograft Implantation During Type I Hybrid Aortic Arch Repair
Hiroshi Banno(Fujisawa City Hospital), Kimihiro Komori(Saiseikai Yahata General Hospital), Akihiko Usui(Fujita Health University), Masayuki Sugimoto(Nagoya University), Akio Kodama(Asahikawa Medical University), Yoshiyuki Tokuda(Nagoya University), Masato Mutsuga(Nagoya University)
Cited by 6
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia
|Circulation Research|2002|238
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold
|Journal of Medicinal Chemistry|2011|223
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias
|Circulation Journal|2021|196